ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $22.03 -1.58 (-6.69%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$21.70 -0.34 (-1.52%) As of 07:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ArriVent BioPharma Stock Price Performance 5 Day Performance-7.05%1 Month Performance-21.85%3 Month Performance-24.68%6 Month Performance-15.66%Year-To-Date Performance-17.30%1 Year Performance-3.16% Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address AVBP Stock Chart for Tuesday, March, 4, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$23.61$22.03-6.69%$23.65$21.92369,910 shs$742.35 million02/28/2025$23.70$23.61-0.38%$24.11$23.17223,593 shs$795.59 million02/27/2025$24.38$23.70-2.79%$25.23$23.54109,595 shs$798.62 million02/26/2025$25.23$24.38-3.37%$26.33$23.29344,717 shs$821.53 million02/25/2025$25.26$25.23-0.12%$26.29$24.72210,604 shs$850.25 million02/24/2025$27.07$25.26-6.69%$27.85$25.02202,432 shs$851.26 million02/21/2025$27.39$27.07-1.17%$27.84$26.61238,021 shs$912.26 million02/20/2025$27.11$27.39+1.03%$28.12$26.93103,427 shs$923.04 million02/19/2025$26.21$27.11+3.43%$27.93$25.97129,078 shs$913.61 million02/18/2025$26.60$26.21-1.47%$28.00$25.89118,706 shs$883.28 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$26.60$26.60$27.21$26.44115,937 shs$896.34 million02/14/2025$26.85$26.60-0.93%$27.21$26.44115,937 shs$896.42 million02/13/2025$26.90$26.85-0.19%$27.45$26.6669,654 shs$904.76 million02/12/2025$26.90$26.90$27.14$26.1091,831 shs$906.53 million02/11/2025$26.91$26.90-0.04%$27.07$26.57110,280 shs$906.53 million02/10/2025$26.09$26.91+3.14%$27.17$26.04124,919 shs$906.87 million02/07/2025$27.38$26.09-4.71%$27.39$25.80345,482 shs$879.23 million02/06/2025$29.25$27.38-6.39%$29.57$27.3385,060 shs$922.71 million02/05/2025$28.19$29.25+3.76%$29.31$27.66272,356 shs$985.73 million02/04/2025$27.56$28.19+2.29%$28.54$26.98137,848 shs$950.00 million02/03/2025$28.54$27.56-3.43%$28.89$25.90174,236 shs$928.77 million Related Companies Rhythm Pharmaceuticals Stock Chart Viking Therapeutics Stock Chart ACADIA Pharmaceuticals Stock Chart Merus Stock Chart Metsera Stock Chart Denali Therapeutics Stock Chart Xenon Pharmaceuticals Stock Chart MorphoSys Stock Chart HUTCHMED Stock Chart Bausch Health Companies Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts